Zurcher Kantonalbank Zurich Cantonalbank Increases Stock Holdings in Embecta Corp. (NASDAQ:EMBC)

Zurcher Kantonalbank Zurich Cantonalbank boosted its position in shares of Embecta Corp. (NASDAQ:EMBC) by 29.4% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 15,003 shares of the company’s stock after acquiring an additional 3,411 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank’s holdings in Embecta were worth $284,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also bought and sold shares of EMBC. Public Employees Retirement System of Ohio boosted its holdings in Embecta by 66.2% in the 3rd quarter. Public Employees Retirement System of Ohio now owns 2,284 shares of the company’s stock valued at $34,000 after purchasing an additional 910 shares during the period. Signaturefd LLC grew its position in Embecta by 1,254.4% during the third quarter. Signaturefd LLC now owns 2,316 shares of the company’s stock worth $35,000 after buying an additional 2,145 shares in the last quarter. NBC Securities Inc. bought a new position in Embecta in the 3rd quarter worth about $44,000. Allworth Financial LP raised its holdings in shares of Embecta by 200.1% in the 3rd quarter. Allworth Financial LP now owns 3,280 shares of the company’s stock valued at $49,000 after acquiring an additional 2,187 shares in the last quarter. Finally, PEAK6 Investments LLC bought a new stake in shares of Embecta during the 3rd quarter valued at about $219,000. Institutional investors own 93.83% of the company’s stock.

Insider Transactions at Embecta

In other news, Director David F. Melcher acquired 2,000 shares of the firm’s stock in a transaction that occurred on Monday, February 12th. The shares were bought at an average cost of $16.25 per share, with a total value of $32,500.00. Following the acquisition, the director now owns 45,080 shares in the company, valued at approximately $732,550. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 0.28% of the company’s stock.

Embecta Trading Down 0.8 %

Shares of NASDAQ EMBC opened at $10.15 on Monday. The business has a 50-day moving average of $12.28 and a 200-day moving average of $15.24. The firm has a market capitalization of $584.44 million, a price-to-earnings ratio of 10.68 and a beta of 0.86. Embecta Corp. has a 12 month low of $9.93 and a 12 month high of $32.00.

Embecta (NASDAQ:EMBC) last released its quarterly earnings results on Friday, February 9th. The company reported $0.61 EPS for the quarter, topping analysts’ consensus estimates of $0.46 by $0.15. The business had revenue of $277.30 million during the quarter, compared to analysts’ expectations of $264.92 million. Embecta had a net margin of 4.93% and a negative return on equity of 18.66%. The business’s quarterly revenue was up .6% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.93 EPS. On average, analysts predict that Embecta Corp. will post 2.14 earnings per share for the current year.

Embecta Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, March 15th. Shareholders of record on Wednesday, February 28th were paid a dividend of $0.15 per share. This represents a $0.60 annualized dividend and a yield of 5.91%. The ex-dividend date was Tuesday, February 27th. Embecta’s dividend payout ratio (DPR) is currently 63.16%.

Embecta Profile

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes.